Addition of Hepatitis C treatments on to the PBS welcomed

Addition of Hepatitis C treatments on to the PBS welcomed

Monday 29 February 2016


Breakthrough anti-viral medications, include medications to treat Hepatitis C, will be available on the Pharmaceutical Benefits Scheme (PBS) from tomorrow, Australian Medical Association (WA) President Dr Michael Gannon said today.


In December 2015, the Federal Government announced a funding package of $1 billion over five years to subsidise a range of breakthrough medicines on the PBS to treat Hepatitis C.


Sofosbuvir with ledipasvir (Harvoni); Sofosbuvir (Sovaldi); Daclatasvir (Daklinza); and Ribavirin (Ibavyr) will be available from 1 March.


These new antiviral treatments have a cure rate of more than 90 per cent. Unlike previous combination therapy treatments, these antivirals can be taken orally over short durations of only 8 to 12 weeks and have fewer side effects for patients.


These new treatments are available to all patients with chronic Hepatitis C infection, across all disease genotypes and disease severities.


GPs will be able to prescribe these antiviral medications in, or following, consultation with a Hepatologist or other Specialist Physician.


“The recent publicity around a case of Hepatitis C transmission at Fiona Stanley Hospital served as a reminder of the need to be vigilant about this potentially lethal infection. Patients with risk factors for transmission like a history of illicit drug use or unprotected sex should talk to their GP about screening.” Dr Gannon said.


“It seems only a few years ago that we were grappling with increasing rates of so-called Non-A Non-B Hepatitis. We now have wonderful new treatments that reduce viral loads to the point where they are undetectable.


“With ‘cure’ rates over 90 per cent, there is optimism that rates of Hepatitis C will be drastically reduced over the next decade. The next frontiers are scientific proof that cure is life-long and the development of a preventative vaccine,” he said.

Have Your Say

Do you support current e-cigarette restrictions in Western Australia?

View Results

Loading ... Loading ...
Why I Joined the AMA (WA)...
"It is my hope that we can tackle the challenges our profession faces, united as one. If we dislike our working hours, our pay, gender inequality or low training opportunities, we can change these together. As a nurse in my previous life, I know that when a profession stands as one, people listen."
Dr Rebecca Cogan
Dr Rebecca Cogan
Perkins researcher develops tool to target the right vein, the first time

Tuesday, 7th January 2020

A medical device start-up established at the Harry Perkins Institute of Medical Research, is aiming to help patients undergoing one of the most common medical procedures.   Along with Emergency Consultant Dr Katherine Arenson and Telethon Kids Researcher Nick Buckley, …